<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230219057451N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-09</date_registration>
      <primary_sponsor>DIponegoro University of Medical Sciences</primary_sponsor>
      <public_title>Peripheral Nerve Block of Serratus Anterior Plane As Analgesia After Modified Radical Mastectomy Surgery</public_title>
      <acronym></acronym>
      <scientific_title>Block of Serratus Anterior Plane As Postoperative Analgesia of Modified Radical Mastectomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-08-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71858</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Method of randomization that we used was simple random sampling procedure. 
The randomization process was performed using numbers randomized by an internet-based computer program (www.randomization.com). The numbers were placed in a sealed envelope. The sealed envelope was opened when the patient arrived at the pre-operation room; then, the patient asked to take one of the papers containing a number. The intervention was given to the subjects selected through randomization based on number in the sealed envelope. Odd numbers were the intervention group, even numbers were the control group, Blinding description: This was double blind clinical trial. The patients who reported their Numeric Rating Scales (NRS) Pain Score scores were blinded to the group assignment because the patient did not know whether they were the control group or the intervention group. The Serratus Anterior Plane Block was performed when patient still unconscious under General Anesthesia. The Investigator and Outcome assessors also blinded to group assignment because NRS pain score assessed after the surgery inthe inpatient ward. So, the outcome assessor and investigator didn’t know which one is the intervention group or control group.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Breast Cancer Patient underwent Radical Mastectomy Surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group :  The treatment group were induced with anesthesia drugs propofol 2 mg/kg BW, rocuronium 0.6 mg/kg BW and were given maintenance with sevoflurane 1 MAC, intravenous paracetamol 1000 mg, and ketorolac intravenously 30 mg. Then were given SAP block using isobaric bupivacaine 0.25% with 20 cc volume. Intervention 2: Control group:  The control group were induced with anesthesia drugs propofol 2 mg/kg BW, rocuronium 0.6 mg/kg BW and were given maintenance with sevoflurane 1 MAC, intravenous paracetamol 1000 mg, and ketorolac intravenously 30 mg. Then were given morphine 20mcg/kg/h continuous infusion as analgesic.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Block of serratus anterior plane as postoperative analgesia of modified radical mastectomy

When:
3 months after publication

To whom:
for people working in academic institutions or people working in businesses can also apply to receive it

Conditions:
as long as they asked permission to the author of this research

Where to obtain:
they could obtain by contacting us via email

How to obtain:
first they must ask permission via email then they made us formal letter to use this data

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Taufan Pramadika</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 32, Mintojiwo Dalam 3</address>
        <city>Semarang</city>
        <country1>Indonesia</country1>
        <zip>50149</zip>
        <telephone>+62 24 7611196</telephone>
        <email>taufanpramadika@gmail.com</email>
        <affiliation>Diponegoro University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mochamat, Mochamat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 15, Mintojiwo Timur</address>
        <city>Semarang</city>
        <country1>Indonesia</country1>
        <zip>50149</zip>
        <telephone>+62 24 7605524</telephone>
        <email>dr.mochamat@gmail.com</email>
        <affiliation>Diponegoro University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Indonesia</country2>
    </countries>
    <criteria>
      <inclusion_criteria>patients who underwent MRM
Age 18-59 years old
Patient with American Society of Anesthesiologist (ASA) class I or II
The patient can also speak verbally and use Numerical Rating Scales (NRS).</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>59 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Patients with opioid allergies were excluded from this study
Patient is known to be taking drugs that are not the research protocol</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C50</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Malignant neoplasm of breast</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group :  The treatment group were induced with anesthesia drugs propofol 2 mg/kg BW, rocuronium 0.6 mg/kg BW and were given maintenance with sevoflurane 1 MAC, intravenous paracetamol 1000 mg, and ketorolac intravenously 30 mg. Then were given SAP block using isobaric bupivacaine 0.25% with 20 cc volume</i_keyword>
      <i_keyword>Control group:  The control group were induced with anesthesia drugs propofol 2 mg/kg BW, rocuronium 0.6 mg/kg BW and were given maintenance with sevoflurane 1 MAC, intravenous paracetamol 1000 mg, and ketorolac intravenously 30 mg. Then were given morphine 20mcg/kg/h continuous infusion as analgesic</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Numeric Rating Scale Pain Score. Timepoint: 4 hours, 8 hours, 12 hours, 24 hours after surgery. Method of measurement: Numeric Rating Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>DIponegoro University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-06-23</approval_date>
        <contact_name>Health Research Ethic Committee RSUP DR. KARIADI SEMARANG</contact_name>
        <contact_address>No 16, DR Sutomo Street Semarang Central Java Indonesia</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
